3 Review(s)

Focused specifically on Life Science Start-Ups Examines how to determine a company valuation and future "fundable milestones" Explores how to align regulatory and clinical strategies Discusses intellectual property derived from a university or individual through formation to exit. Reviews how start-ups must simultaneously meet the needs of multiple constituencies at once: investors, regulators, customers and exit candidates